Research Article
Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report
Table 2
Summary of patients group characteristics including the baselines age, sex, duration of treatment, and the dosage.
| | Group | Age median range (low high) | Male/female | duration | Dosage mg dd (median range (low high)) |
| | A | 58 (40–76) | 0/5 | >2–8 years | 5 (3–10) | | B | 43 (26–60) | 4/7 | >2–8 years | 10 (5–15) | | C | 48 (18–77) | 15/9 | >2–8 years | 10 (3–15) | | D | 44 (24–70) | 7/4 | 2 (0,5–6) | 5 (5–12,5) |
|
|
